{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:41:08Z","timestamp":1769172068231,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00392-018-1385-1","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T07:24:28Z","timestamp":1539933868000},"page":"549-561","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prognostic value of estimated plasma volume in acute heart failure in three cohort studies"],"prefix":"10.1007","volume":"108","author":[{"given":"Masatake","family":"Kobayashi","sequence":"first","affiliation":[]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Irene","family":"Arag\u00e3o","sequence":"additional","affiliation":[]},{"given":"Yuki","family":"Paku","sequence":"additional","affiliation":[]},{"given":"Yoichi","family":"Iwasaki","sequence":"additional","affiliation":[]},{"given":"Masataka","family":"Watanabe","sequence":"additional","affiliation":[]},{"given":"Marat","family":"Fudim","sequence":"additional","affiliation":[]},{"given":"Kevin","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","volume":"12","author":"M Gheorghiade","year":"2010","unstructured":"Gheorghiade M, Follath F, Ponikowski P et al (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12:423\u2013433","journal-title":"Eur J Heart Fail"},{"key":"1385_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/eurheartj\/ehs444","volume":"34","author":"AP Ambrosy","year":"2013","unstructured":"Ambrosy AP, Pang PS, Khan S et al (2013) Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J 34:835\u2013843","journal-title":"Eur Heart J"},{"key":"1385_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-018-1283-6","author":"Y Shiraishi","year":"2018","unstructured":"Shiraishi Y, Nagai T, Kohsaka S et al (2018) Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-018-1283-6","journal-title":"Clin Res Cardiol"},{"key":"1385_CR4","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1002\/ejhf.344","volume":"17","author":"S Coiro","year":"2015","unstructured":"Coiro S, Rossignol P, Ambrosio G et al (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172\u20131181","journal-title":"Eur J Heart Fail"},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00392-018-1221-7","volume":"107","author":"A Palazzuoli","year":"2018","unstructured":"Palazzuoli A, Ruocco G, Beltrami M, Nuti R, Cleland JG (2018) Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF. Clin Res Cardiol 107:586\u2013596","journal-title":"Clin Res Cardiol"},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cardfail.2017.04.014","volume":"23","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B et al (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail 23:628\u2013651","journal-title":"J Card Fail"},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975","journal-title":"Eur J Heart Fail"},{"key":"1385_CR8","doi-asserted-by":"crossref","unstructured":"Girerd N, Seronde MF, Coiro S et al. Integrative assessment of congestion in heart failure throughout the patient journey. J Am Coll Cardiol 2017","DOI":"10.1016\/j.jchf.2017.09.023"},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.jacc.2011.04.049","volume":"58","author":"P Rossignol","year":"2011","unstructured":"Rossignol P, Menard J, Fay R, Gustafsson F, Pitt B, Zannad F (2011) Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol 58:1958\u20131966","journal-title":"J Am Coll Cardiol"},{"key":"1385_CR10","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.jchf.2015.06.014","volume":"3","author":"K Duarte","year":"2015","unstructured":"Duarte K, Monnez JM, Albuisson E, Pitt B, Zannad F, Rossignol P (2015) Prognostic value of estimated plasma volume in heart failure. JACC Heart Fail 3:886\u2013893","journal-title":"JACC Heart Fail"},{"key":"1385_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10741-011-9244-4","volume":"16","author":"R Valle","year":"2011","unstructured":"Valle R, Aspromonte N, Milani L et al (2011) Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels. Heart Fail Rev 16:519\u2013529","journal-title":"Heart Fail Rev"},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1365-2141.1973.tb01792.x","volume":"25","author":"Standard Techinique for the measurement of red-cell and plasma volume","year":"1973","unstructured":"Standard Techinique for the measurement of red-cell and plasma volume (1973) A report by the International Committe for Standardization in Hematology (ICSH): panel on diagnostic applications of radioisotopes in haematology. Br J Haematol 25:801\u2013814","journal-title":"Br J Haematol"},{"key":"1385_CR13","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/S0735-1097(02)01903-4","volume":"39","author":"PR Kalra","year":"2002","unstructured":"Kalra PR, Anagnostopoulos C, Bolger AP, Coats AJS, Anker SD (2002) The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39:1901\u20131908","journal-title":"J Am Coll Cardiol"},{"key":"1385_CR14","doi-asserted-by":"crossref","unstructured":"Yoshihisa A, Abe S, Sato Y et al. Plasma volume status predicts prognosis in patients with acute heart failure syndromes. Eur Heart J Acute Cardiovasc Care 2017:2048872617690889","DOI":"10.1177\/2048872617690889"},{"key":"1385_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ejhf.193","volume":"17","author":"HZ Ling","year":"2015","unstructured":"Ling HZ, Flint J, Damgaard M et al (2015) Calculated plasma volume status and prognosis in chronic heart failure. Eur J Heart Fail 17:35\u201343","journal-title":"Eur J Heart Fail"},{"key":"1385_CR16","doi-asserted-by":"publisher","first-page":"e3307","DOI":"10.1097\/MD.0000000000003307","volume":"95","author":"JP Ferreira","year":"2016","unstructured":"Ferreira JP, Girerd N, Arrigo M et al (2016) Enlarging red blood cell distribution width during hospitalization identifies a very high-risk subset of acutely decompensated heart failure patients and adds valuable prognostic information on top of hemoconcentration. Medicine (Baltimore) 95:e3307","journal-title":"Medicine (Baltimore)"},{"key":"1385_CR17","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.ijcard.2013.05.090","volume":"168","author":"N Agrinier","year":"2013","unstructured":"Agrinier N, Altieri C, Alla F et al (2013) Effectiveness of a multidimensional home nurse led heart failure disease management program\u2013a French nationwide time-series comparison. Int J Cardiol 168:3652\u20133658","journal-title":"Int J Cardiol"},{"key":"1385_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461\u2013470","journal-title":"Ann Intern Med"},{"key":"1385_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1172\/JCI102501","volume":"30","author":"MB Strauss","year":"1951","unstructured":"Strauss MB, Davis RK, Rosenbaum JD, Rossmeisl EC (1951) Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest 30:862\u2013868","journal-title":"J Clin Invest"},{"key":"1385_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.amjcard.2008.04.054","volume":"102","author":"JM Olson","year":"2008","unstructured":"Olson JM, Samad BA, Alam M (2008) Prognostic value of pulse-wave tissue Doppler parameters in patients with systolic heart failure. Am J Cardiol 102:722\u2013725","journal-title":"Am J Cardiol"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/echo.12617","volume":"32","author":"E Santas","year":"2015","unstructured":"Santas E, Garcia-Blas S, Minana G et al (2015) Prognostic implications of tissue Doppler imaging-derived e\/ea ratio in acute heart failure patients. Echocardiography 32:213\u2013220","journal-title":"Echocardiography"},{"key":"1385_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/2048872616641281","volume":"6","author":"S Santarelli","year":"2017","unstructured":"Santarelli S, Russo V, Lalle I et al (2017) Prognostic value of decreased peripheral congestion detected by bioelectrical impedance vector analysis (BIVA) in patients hospitalized for acute heart failure: BIVA prognostic value in acute heart failure. Eur Heart J Acute Cardiovasc Care 6:339\u2013347","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1385_CR23","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","volume":"361","author":"SD Anker","year":"2003","unstructured":"Anker SD, Negassa A, Coats AJS et al (2003) Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361:1077\u20131083","journal-title":"Lancet"},{"key":"1385_CR24","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00392-015-0945-x","volume":"105","author":"JP Ferreira","year":"2016","unstructured":"Ferreira JP, Girerd N, Medeiros PB et al (2016) Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect. Clin Res Cardiol 105:489\u2013507","journal-title":"Clin Res Cardiol"},{"key":"1385_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.14740\/jocmr2691w","volume":"8","author":"R Vecchis De","year":"2016","unstructured":"De Vecchis R, Ariano C, Giandomenico G, Di Maio M, Baldi C (2016) Change of serum BNP between admission and discharge after acute decompensated heart failure is a better predictor of 6-month all-cause mortality than the single BNP value determined at admission. J Clin Med Res 8:737\u2013742","journal-title":"J Clin Med Res"},{"key":"1385_CR26","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCHEARTFAILURE.111.962290","volume":"4","author":"RD Kociol","year":"2011","unstructured":"Kociol RD, Horton JR, Fonarow GC et al (2011) Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims. Circ Heart Fail 4:628\u2013636","journal-title":"Circ Heart Fail"},{"key":"1385_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCULATIONAHA.109.933275","volume":"122","author":"JM Testani","year":"2010","unstructured":"Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP (2010) Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122:265\u2013272","journal-title":"Circulation"},{"key":"1385_CR28","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.jacc.2012.12.050","volume":"61","author":"P Meer van der","year":"2013","unstructured":"van der Meer P, Postmus D, Ponikowski P et al (2013) The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61:1973\u20131981","journal-title":"J Am Coll Cardiol"},{"key":"1385_CR29","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/eurjhf\/hft110","volume":"15","author":"SJ Greene","year":"2013","unstructured":"Greene SJ, Gheorghiade M, Vaduganathan M et al (2013) Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15:1401\u20131411","journal-title":"Eur J Heart Fail"},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jacc.2013.05.027","volume":"62","author":"JM Testani","year":"2013","unstructured":"Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH (2013) Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62:516\u2013524","journal-title":"J Am Coll Cardiol"},{"key":"1385_CR31","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/ejhf.282","volume":"17","author":"H Khan","year":"2015","unstructured":"Khan H, Greene SJ, Fonarow GC et al (2015) Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial. Eur J Heart Fail 17:1022\u20131031","journal-title":"Eur J Heart Fail"},{"key":"1385_CR32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/ejhf.540","volume":"18","author":"BA Davison","year":"2016","unstructured":"Davison BA, Metra M, Senger S et al (2016) Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality. Eur J Heart Fail 18:1041\u20131050","journal-title":"Eur J Heart Fail"},{"key":"1385_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.amjcard.2017.03.249","volume":"120","author":"AP Ambrosy","year":"2017","unstructured":"Ambrosy AP, Bhatt AS, Gallup D et al (2017) Trajectory of congestion metrics by ejection fraction in patients with acute heart failure (from the heart failure network). Am J Cardiol 120:98\u2013105","journal-title":"Am J Cardiol"},{"key":"1385_CR34","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00392-016-1063-0","volume":"106","author":"D Farmakis","year":"2017","unstructured":"Farmakis D, Simitsis P, Bistola V et al (2017) Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol 106:359\u2013368","journal-title":"Clin Res Cardiol"},{"key":"1385_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00392-016-1009-6","volume":"105","author":"S Ishihara","year":"2016","unstructured":"Ishihara S, Gayat E, Sato N et al (2016) Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure. Clin Res Cardiol 105:971\u2013980","journal-title":"Clin Res Cardiol"},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","volume":"32","author":"BA Borlaug","year":"2011","unstructured":"Borlaug BA, Paulus WJ (2011) Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. European heart journal 32:670\u2013679","journal-title":"European heart journal"},{"key":"1385_CR37","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.jacc.2017.03.528","volume":"69","author":"MR Costanzo","year":"2017","unstructured":"Costanzo MR, Ronco C, Abraham WT et al (2017) Extracorporeal ultrafiltration for fluid overload in heart failure: current status and prospects for further research. J Am Coll Cardiol 69:2428\u20132445","journal-title":"J Am Coll Cardiol"},{"key":"1385_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2018.07.462","author":"M Fudim","year":"2018","unstructured":"Fudim M, Miller WL (2018) Calculated estimates of plasma volume in patients with chronic heart failure-comparison with measured volumes. J Card Fail. https:\/\/doi.org\/10.1016\/j.cardfail.2018.07.462","journal-title":"J Card Fail"}],"updated-by":[{"DOI":"10.1007\/s00392-018-1390-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000}}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1385-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1385-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T07:32:46Z","timestamp":1662276766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1385-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1385-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"PR, JF, FZ and NG are supported by a public grant overseen by the French National Research Agency (ANR) as part of the second \u201cInvestissements d\u2019Avenir\u201d program FIGHT-HF (reference: ANR-15-RHU-0004). F.Z. has received consulting fees from Actelion, Amgen, AstraZeneca, Bayer, Boehringer, Boston Science, CEVA, CVRx, Vifor-Fresenius, GE Healthcare, J&J, KBP BioSciences, Livanova, Novartis, NovoNordisk, Pfizer, Quantum Genomics, Relypsa, Resmed, Roche, Takeda and ZS pharma. P.R. has received fees from Honoraria, research grants and\/or travel grants from AstraZeneca, Bayer, BG Medicine, BMS, CVRx, Daichii-Sankyo, Fresenius, Gambro, HAC-Pharma, Novartis, Relypsa, Roche, Sanofi, Servier, Stealth Peptides, CTMA and Vifor Fresenius Medical Care Renal Pharma. N.G. has received Board and consulting Fees (Honoraria) for Novartis and consulting fees (Honoraria) for Servier. M.F. received a grant from the American Heart Association and consulting fees from Coridea, Axon Therapies, Galvani and GE Healthcare. M.W. has received consulting fees from Medtronic and Philips, and Y.I. has received consulting fees from Medtronic. All other authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}